The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting

Research output: Contribution to journalReview articlepeer-review

Abstract

The prognostic value of the immune cell infiltrate in the breast carcinoma microenvironment is still uncertain. We reviewed published articles analysing the infiltration of inflammatorycells in the microenvironment of breast carcinoma. Data revealed the importance of infiltration of these immune cells in the prognosis of breast carcinoma, particularly the triple-negative and HER2-positive phenotypes. Tumour-infiltrating lymphocytes and their subtypes play a fundamental role in predicting the pathological complete response (pCR) to neoadjuvant chemotherapy. More research aiming to dissect a complex network of communication between cancer cells and other cellular components of the tumour microenvironment is necessary to develop more effective therapeutic approaches.

Original languageEnglish
Pages (from-to)61-74
Number of pages14
JournalPathobiology
Volume87
Issue number2
Early online date12 Nov 2019
DOIs
Publication statusPublished - May 2020

Bibliographical note

© 2019 S. Karger AG, Basel.

Keywords

  • Biomarkers, Tumor
  • Breast Neoplasms/immunology
  • Female
  • Humans
  • Lymphocytes, Tumor-Infiltrating/classification
  • Neoadjuvant Therapy
  • Prognosis
  • Signal Transduction/immunology
  • Triple Negative Breast Neoplasms/immunology
  • Tumor Microenvironment/immunology

Fingerprint

Dive into the research topics of 'The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting'. Together they form a unique fingerprint.

Cite this